Meeting
2022 ASCO Annual Meeting
Trial in progress: A randomized phase II study of pembrolizumab with or without defactinib, a focal adhesion kinase inhibitor, following chemotherapy as a neoadjuvant and adjuvant treatment for resectable pancreatic ductal adenocarcinoma (PDAC).
Authors
John Davelaar
Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA
John Davelaar , Zachariah Brown , Sheila Linden , Christina Rodriguez , Omer Elmadbouh , Jonathan A. Pachter , Jun Gong , Andrew Eugene Hendifar , Simon Lo , Srinivas Gaddam , Nicholas Nissen , Richard A. Burkhart , Lei Zheng , Arsen Osipov
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Clinical Trial Registration Number
NCT03727880
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr TPS4192)
DOI
10.1200/JCO.2022.40.16_suppl.TPS4192
Abstract #
TPS4192
Poster Bd #
161a
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Preliminary translational immune and stromal correlates in a randomized phase II trial of pembrolizumab with or without defactinib for resectable pancreatic ductal adenocarcinoma (PDAC).
First Author: Anser Ali Abbas
Poster
2018 ASCO Annual Meeting
Phase I study of defactinib combined with pembrolizumab and gemcitabine in patients with advanced cancer.
First Author: Andrea Wang-Gillam
Poster
2017 Gastrointestinal Cancers Symposium
Phase I study of defactinib combined with pembrolizumab and gemcitabine in advanced cancer.
First Author: Andrea Wang-Gillam
Poster
2024 ASCO Annual Meeting
Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC): Preliminary findings.
First Author: Benjamin Adam Weinberg